Hydrogel implant technology offers new hope for women seeking reversible sterilization and endometriosis treatment

FHS
July 19, 2024
8:48 am

Hydrogel implants for reversible fallopian tube occlusion, providing contraception and preventing endometriosis.

‘New Gold Standard’ for Previously Untreated CLL

SAN DIEGO — A time-limited, targeted combination significantly improved survival compared with chemoimmunotherapy in fit chronic lymphocytic leukemia (CLL) patients who met criteria for starting

December 11, 2023

Johnson & Johnson agrees to acquire Ambrx Biopharma for $2bn

Share this article The acquisition of Ambrx by Johnson & Johnson is anticipated to conclude in the first half of 2024. Credit: josefkubes / Shutterstock.com.

January 9, 2024

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. Execute Agreement for $27 Million Funding Transaction for HOPE Clinic Acquisition | Psychedelic Invest

MIAMI – HOPE Therapeutics, Inc. (‘HOPE’), a medical and technology driven company, and a wholly-owned subsidiary of NRx Pharmaceuticals, Inc. (‘NRx’, and collectively with HOPE, the ‘Company’) (Nasdaq: NRXP), today

January 31, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.